Skip to main content

Find Clinical Trials

Home
Conditions
Respiratory Tract Neoplasms

Clinical trial condition

Respiratory Tract Neoplasms

Explore clinical trials studying Respiratory Tract Neoplasms. Study availability and eligibility vary by location and protocol.

8,163 public trials 1,868 recruiting studies

Refine in advanced search Browse all conditions

Respiratory Tract Neoplasms trial results

Completed

mil60 Versus Bevacizumab in Patients With Treatment-naïve Non-squamous Non-small Cell Lung Cancer

NCT03196986

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Cancer Institute/Hospital, Chinese Academy of Medical Sciences Beijing, China

Peking University Shenzhen Hospital Shenzhen, China

View Trial Details

Completed

Open-label PET Study With [11C]Osimertinib in Patients With EGFRm NSCLC and Brain Metastases

NCT03463525

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Research Site Stockholm, Sweden

View Trial Details

Completed

A Phase 1 Drug-Drug Interaction Study Between Brigatinib and the CYP3A Substrate, Midazolam, in Participants With ALK-Positive or ROS1-Positive Solid Tumors

NCT03420742

Conditions: Carcinoma, Carcinoma, Advanced ALK+ or ROS1+Non-Small-Cell Lung, Neoplasm, Advanced ALK+ or ROS1+Solid Tumors, Lung Diseases, +8 more
Locations: Hopital de la Timone Marseille, Provence-Alpes-Côte d'Azur Region, France

Groupe Hospitalier Bichat-Claude Bernard - Hopital Bichat Paris, Île-de-France Region, France

Centro di Riferimento Oncologico di Aviano Aviano, Pordenone, Italy

Policlinico Sant'Orsola Malpighi Bologna, Italy

View all 14 locations

View Trial Details

Completed

Certolizumab in Combination With Chemotherapy for Patients With Stage IV Lung Adenocarcinomas

NCT02120807

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Carcinoma, +8 more
Locations: Memorial Sloan Kettering at Basking Ridge Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States

Memorial Sloan Kettering West Harrison Harrison, New York, United States

Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Safety and Efficacy Study of AMG 820 and Pembrolizumab Combination in Select Advanced Solid Tumor Cancer

NCT02713529

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +23 more
Locations: Research Site Atlanta, Georgia, United States

Research Site Boston, Massachusetts, United States

Research Site Boston, Massachusetts, United States

Research Site Grand Rapids, Michigan, United States

View all 15 locations

View Trial Details

Completed

A Phase I/IB Trial of MEK162 in Combination With Erlotinib in NSCLC Harboring KRAS or EGFR Mutation

NCT01859026

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Completed

Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S

NCT04430842

Conditions: Adenocarcinoma, Adenoma, Adnexal Diseases, +129 more
Locations: St George Private Hospital Kogarah, New South Wales, Australia

Sydney Southwest Private Hospital Liverpool, New South Wales, Australia

View Trial Details

Completed

Patient Portal and Navigation Program in Providing Information for Asian American Cancer Patients

NCT03867916

Conditions: Caregiver, Colonic Diseases, Colorectal Neoplasms, +42 more
Locations: University of California, San Francisco San Francisco, California, United States

View Trial Details

Completed

Exparel and Marcaine for Pain Management in Thoracoscopic Lobectomy Patients

NCT03682224

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
Locations: Memorial Medical Center, Southern Illinois University-School of Medicine Springfield, Illinois, United States

View Trial Details

Completed

A Study of PDR001 in Combination With LCL161, Everolimus or Panobinostat

NCT02890069

Conditions: Adenocarcinoma, Breast Diseases, Breast Neoplasms, +36 more
Locations: UCLA Santa Monica Hematology / Oncology SC Santa Monica, California, United States

Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States

Massachusetts General Hospital Boston, Massachusetts, United States

The Regents of the University of Michigan Ann Arbor, Michigan, United States

View all 25 locations

View Trial Details